MétaCan
Menu
← Back to cohort
Record W4312087787 · doi:10.1002/alz.066330

Baseline blood amylin levels predict longitudinal cognitive decline in participants at risk for or with mild cognitive impairment and dementia

2022· article· en· W4312087787 on OpenAlexaboutno aff
Gregory A. Jicha, Larry B. Goldstein, Donna M. Wilcock, Florin Despa

Bibliographic record

VenueAlzheimer s & Dementia · 2022
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsnot available
Fundersnot available
KeywordsDementiaInternal medicineAmylinLongitudinal studyMontreal Cognitive AssessmentMedicineCognitive declineDiabetes mellitusCohortCognitionPsychologyCardiologyInsulinEndocrinologyPsychiatryPathologyDisease

Abstract

fetched live from OpenAlex

Abstract Background Amylin is a systemic hormone that is co‐secreted with insulin from pancreatic β‐cells that co‐aggregates with parenchymal and vascular b‐amyloid in the CNS. Cross‐sectional data shows that higher CSF and blood amylin levels are associated with increased frequency of cognitive impairment and dementia. The present study sought to determine whether baseline blood amylin levels are associated with longitudinal cognitive decline. Method Whole blood amylin levels were ascertained from 83 participants in a longitudinal cohort spanning the cognitive continuum from normal to MCI and dementia who were evaluated initially in 2017 and followed to present. Cognitive change data including MMSE, MoCA, CDR global and sum‐of‐box scores at baseline and longitudinal follow‐up were analyzed in relation to baseline amylin levels. Result Participants were followed for a mean 2.0 ± 1.1 years. Baseline whole blood amylin levels varied widely (mean of 8.8 ± 12.2 pg/ml). Seventy‐one participants had complete baseline and follow‐up data were included in this analysis. Of these, 20 had objective evidence for longitudinal decline. Participants with above vs below modal baseline amylin levels scored lower on baseline and follow‐up assessment scores including MMSE, MoCA, CDR global and CDR sum‐of box scores (p‐values all < 0.05). Annualized cognitive change scores (loss) for the MMSE (1.4 ± 2.4 vs. 0.3 ± 1.3; p < 0.05) and MoCA (1.5 ± 2.5 vs. 0.4 ± 1.8; p < 0.05) were greater in the above median baseline amylin level vs below median groups. Conclusion Baseline amylin whole blood levels are predictive of objective decline in MMSE and MoCA scores over periods as short as 2 years. These data suggest that the higher pancreatic hormone amylin may accelerate disease pathogenesis and cognitive decline as a result of altered pancreatic β‐cell function, potentially explaining, at least in part, the strong epidemiologic link between diabetes and dementia found across global observational cohorts. These data further suggest that the use of amylin biomarkers may serve as a useful tool for identifying subjects at high risk for short term cognitive decline. Additional work elucidating the role of amylin in degenerative disease cascades is warranted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.065
GPT teacher head0.343
Teacher spread0.279 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicDementia and Cognitive Impairment Research→French-language works237,207→